S&P 500   4,604.39 (+0.00%)
DOW   36,331.78 (+0.23%)
QQQ   393.09 (+0.23%)
AAPL   191.81 (-1.99%)
MSFT   368.63 (-1.50%)
META   321.03 (-3.52%)
GOOGL   132.33 (-1.97%)
AMZN   144.88 (-1.72%)
TSLA   239.89 (-1.62%)
NVDA   460.18 (-3.13%)
NIO   7.47 (+1.22%)
BABA   71.52 (-0.86%)
AMD   133.34 (+3.43%)
T   16.67 (-1.48%)
F   11.09 (+0.73%)
MU   77.70 (+3.66%)
CGC   0.81 (+0.73%)
GE   120.29 (-0.25%)
DIS   92.74 (-0.09%)
AMC   6.85 (-1.15%)
PFE   28.57 (-0.73%)
PYPL   59.31 (+0.63%)
XOM   99.25 (-0.30%)
S&P 500   4,604.39 (+0.00%)
DOW   36,331.78 (+0.23%)
QQQ   393.09 (+0.23%)
AAPL   191.81 (-1.99%)
MSFT   368.63 (-1.50%)
META   321.03 (-3.52%)
GOOGL   132.33 (-1.97%)
AMZN   144.88 (-1.72%)
TSLA   239.89 (-1.62%)
NVDA   460.18 (-3.13%)
NIO   7.47 (+1.22%)
BABA   71.52 (-0.86%)
AMD   133.34 (+3.43%)
T   16.67 (-1.48%)
F   11.09 (+0.73%)
MU   77.70 (+3.66%)
CGC   0.81 (+0.73%)
GE   120.29 (-0.25%)
DIS   92.74 (-0.09%)
AMC   6.85 (-1.15%)
PFE   28.57 (-0.73%)
PYPL   59.31 (+0.63%)
XOM   99.25 (-0.30%)
S&P 500   4,604.39 (+0.00%)
DOW   36,331.78 (+0.23%)
QQQ   393.09 (+0.23%)
AAPL   191.81 (-1.99%)
MSFT   368.63 (-1.50%)
META   321.03 (-3.52%)
GOOGL   132.33 (-1.97%)
AMZN   144.88 (-1.72%)
TSLA   239.89 (-1.62%)
NVDA   460.18 (-3.13%)
NIO   7.47 (+1.22%)
BABA   71.52 (-0.86%)
AMD   133.34 (+3.43%)
T   16.67 (-1.48%)
F   11.09 (+0.73%)
MU   77.70 (+3.66%)
CGC   0.81 (+0.73%)
GE   120.29 (-0.25%)
DIS   92.74 (-0.09%)
AMC   6.85 (-1.15%)
PFE   28.57 (-0.73%)
PYPL   59.31 (+0.63%)
XOM   99.25 (-0.30%)
S&P 500   4,604.39 (+0.00%)
DOW   36,331.78 (+0.23%)
QQQ   393.09 (+0.23%)
AAPL   191.81 (-1.99%)
MSFT   368.63 (-1.50%)
META   321.03 (-3.52%)
GOOGL   132.33 (-1.97%)
AMZN   144.88 (-1.72%)
TSLA   239.89 (-1.62%)
NVDA   460.18 (-3.13%)
NIO   7.47 (+1.22%)
BABA   71.52 (-0.86%)
AMD   133.34 (+3.43%)
T   16.67 (-1.48%)
F   11.09 (+0.73%)
MU   77.70 (+3.66%)
CGC   0.81 (+0.73%)
GE   120.29 (-0.25%)
DIS   92.74 (-0.09%)
AMC   6.85 (-1.15%)
PFE   28.57 (-0.73%)
PYPL   59.31 (+0.63%)
XOM   99.25 (-0.30%)

Pharming Group (PHAR) News Today

$11.32
-0.68 (-5.67%)
(As of 10:25 AM ET)
Compare
Today's Range
$11.32
▼
$11.35
50-Day Range
$10.00
▼
$12.50
52-Week Range
$9.65
▼
$17.81
Volume
662 shs
Average Volume
10,344 shs
Market Capitalization
$757.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$38.50
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
msn.com logoPharming doses first paediatric patient in APDS therapy trial
msn.com - November 22 at 12:44 PM
markets.businessinsider.com logoPharming Group’s Promising Clinical Trials and Regulatory Advancements Drive Analyst’s Buy Rating
markets.businessinsider.com - November 22 at 7:44 AM
markets.businessinsider.com logoPharming Group: Positive Outlook Based on Leniolisib’s Global Regulatory Traction and Successful Joenja Launch
markets.businessinsider.com - November 11 at 7:21 AM
morningstar.com logoPharming Group ADR PHAR
morningstar.com - November 6 at 6:38 PM
morningstar.com logoPharming Group PHARM
morningstar.com - November 4 at 3:41 PM
finanznachrichten.de logoPharming Group N.V.: Pharming Group to participate in November investor conferences
finanznachrichten.de - November 1 at 8:21 AM
finance.yahoo.com logoPharming Group to participate in November investor conferences
finance.yahoo.com - November 1 at 8:21 AM
seekingalpha.com logoPharming Group N.V. 2023 Q3 - Results - Earnings Call Presentation
seekingalpha.com - October 26 at 9:34 AM
marketbeat.com logo
marketbeat.com - September 29 at 3:58 PM
finanznachrichten.de logoPharming Group N.V.: Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
finanznachrichten.de - September 25 at 3:12 PM
markets.businessinsider.com logoPharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
markets.businessinsider.com - September 25 at 3:12 PM
markets.businessinsider.com logoRBC Capital Reaffirms Their Buy Rating on Pharming Group (PHGUF)
markets.businessinsider.com - September 6 at 11:54 PM
finance.yahoo.com logoPharming Group to participate in September investor conferences
finance.yahoo.com - August 24 at 2:49 AM
finance.yahoo.com logoPharming Group to convene Extraordinary General Meeting of Shareholders
finance.yahoo.com - August 14 at 3:00 AM
msn.com logoPharming Group enrols first patient in APDS therapy trial
msn.com - August 10 at 9:42 AM
finanznachrichten.de logoPharming Group N.V.: Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
finanznachrichten.de - August 9 at 1:36 AM
prnewswire.com logoPharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
prnewswire.com - August 9 at 1:00 AM
seekingalpha.com logoPharming Group N.V. 2023 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 5 at 4:32 AM
marketbeat.com logoPharming Group (PHAR) Scheduled to Post Quarterly Earnings on Thursday
marketbeat.com - July 27 at 2:59 AM
nasdaq.com logoPharming Group Nominates Richard Peters To Become Chairman
nasdaq.com - July 18 at 7:46 AM
finance.yahoo.com logoPHAR - Pharming Group N.V.
finance.yahoo.com - July 7 at 2:04 PM
msn.com logo'Don't talk to strangers.' Top scams on seniors for 2023 and how to defend yourself
msn.com - June 18 at 3:41 PM
msn.com logoPharming sells rare pediatric disease PRV to Novartis for $21.1M
msn.com - June 1 at 12:57 PM
finance.yahoo.com logoPharming announces sale of priority review voucher
finance.yahoo.com - June 1 at 2:36 AM
finance.yahoo.com logoPharming Group to attend the following Investor Conferences in June
finance.yahoo.com - May 25 at 9:47 AM
finanznachrichten.de logoPharming Group N.V.: Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders
finanznachrichten.de - May 17 at 2:53 PM
finance.yahoo.com logoPharming Group reports on results of the 2023 Annual General Meeting of Shareholders
finance.yahoo.com - May 17 at 2:53 PM
marketwatch.com logoLactoferrin and Lactoperoxidase Market with Future Opportunities 2023-2030
marketwatch.com - May 16 at 1:50 PM
msn.com logoAssociated Capital Group GAAP EPS of $0.81, revenue of $2.47M
msn.com - May 11 at 8:46 PM
finanznachrichten.de logoPharming Group N.V.: Pharming Group reports financial results for the first quarter of 2023
finanznachrichten.de - May 11 at 5:45 AM
marketwatch.com logoLactoferrin and Lactoperoxidase Market [2023-2030] | Global Size and Growth Developments
marketwatch.com - May 8 at 4:44 PM
marketwatch.com logoHereditary Angioedema Market Size by 2030
marketwatch.com - April 28 at 8:23 PM
marketwatch.com logoHereditary Angioedema Treatment Market Outlook by 2031
marketwatch.com - April 27 at 6:24 PM
seekingalpha.com logoPharming Group: Small Company, Unclear Management Style, Low Volume
seekingalpha.com - April 17 at 12:50 PM
marketbeat.com logoPharming Group (NASDAQ:PHAR) Sees Large Growth in Short Interest
marketbeat.com - April 14 at 12:53 PM
finanznachrichten.de logoPharming Group N.V.: Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023
finanznachrichten.de - April 13 at 7:41 AM
finance.yahoo.com logoPharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023
finance.yahoo.com - April 13 at 7:41 AM
finanznachrichten.de logoPharming Group: Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.
finanznachrichten.de - April 11 at 9:18 AM
finance.yahoo.com logoPharming Group convenes the Annual General Meeting of Shareholders 2023
finance.yahoo.com - April 5 at 8:06 AM
seekingalpha.com logoPHAR Pharming Group N.V.
seekingalpha.com - March 31 at 4:58 PM
benzinga.com logoPharming Group shares are trading higher after Oppenheimer maintained an Outperform rating and raised its price target from $36 to $40.
benzinga.com - March 29 at 10:14 AM
markets.businessinsider.com logoOppenheimer Maintains Outperform Rating for Pharming: Here's What You Need To Know
markets.businessinsider.com - March 28 at 2:09 PM
marketwatch.com logoUS FDA approves PharmingaEUR(TM)s Joenja to treat APDS
marketwatch.com - March 28 at 8:48 AM
finance.yahoo.com logoPharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up
finance.yahoo.com - March 27 at 1:32 PM
benzinga.com logoBioNTech, Coinbase Global, Pharming Group And Other Big Stocks Moving Lower On Monday
benzinga.com - March 27 at 12:17 PM
marketwatch.com logoPharming announces US FDA approval of Joenja(R) (leniolisib) as the first and only treatment indicated for APDS
marketwatch.com - March 26 at 5:37 PM
reuters.com logoU.S. judge rules Internet Archive's digital book lending violates copyrights
reuters.com - March 25 at 1:40 AM
markets.businessinsider.com logoPharming Stock Reaps Significant Gains After Landmark FDA Approval
markets.businessinsider.com - March 25 at 1:40 AM
marketwatch.com logoPharming Announces FDA Approval of Joenja, ADRs Rise 46%
marketwatch.com - March 24 at 8:36 PM
marketwatch.com logoADRs End Mostly Lower, Pharming Group Trades Actively
marketwatch.com - March 24 at 8:36 PM
Get Pharming Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter.



PHAR Media Mentions By Week

PHAR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PHAR
News Sentiment
▼
0.00

0.53
▲
Average
Medical
News Sentiment

PHAR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PHAR Articles
This Week
▼
0

1
▲
PHAR Articles
Average Week

Get Pharming Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:PHAR) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -